New Biomarker Identified in Breast and Prostate Cancers Holds Promise for Treating Disease (IMAGE)
Caption
Cedars-Sinai researchers have identified a novel genetic biomarker responsible for the progression of many breast and prostate cancers. The finding could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs that attack the most aggressive forms of cancer.
Credit
Cedars-Sinai
Usage Restrictions
None
License
Licensed content